Development of a Novel Drug Delivery System for Targeted Cancer Therapy

Thesis Abstract

Abstract
Cancer remains a significant global health challenge, prompting the continuous exploration of innovative treatment strategies to improve patient outcomes. The development of a novel drug delivery system tailored specifically for targeted cancer therapy represents a promising approach in the fight against this complex disease. This thesis focuses on the design, optimization, and evaluation of a novel drug delivery system that aims to enhance the efficacy and reduce the side effects of cancer therapy through targeted drug delivery. The introduction sets the stage by providing a comprehensive overview of the current landscape of cancer treatment and the limitations of existing drug delivery systems. The background of the study delves into the scientific rationale behind targeted drug delivery and highlights the potential benefits it offers in terms of precision, efficiency, and reduced toxicity. The problem statement underscores the urgent need for more effective cancer treatment modalities that can address the challenges associated with conventional systemic drug administration. The objectives of the study are outlined to guide the research process towards achieving specific goals, including the development of a novel drug delivery system, optimization of drug loading and release kinetics, evaluation of in vitro and in vivo efficacy, and comparison with existing treatment modalities. The limitations of the study are acknowledged, providing insights into the constraints and challenges encountered during the research process. The scope of the study delineates the boundaries within which the research is conducted, focusing on specific aspects of drug delivery system development, characterization, and evaluation. The significance of the study underscores the potential impact of this research on advancing the field of cancer therapy and improving patient outcomes through targeted drug delivery. The literature review critically examines existing studies and technologies related to drug delivery systems for cancer therapy, highlighting key findings, challenges, and opportunities for innovation. The research methodology details the experimental approach, materials, and methods employed in designing, synthesizing, and testing the novel drug delivery system. The discussion of findings presents a detailed analysis of the experimental results, including drug loading efficiency, release kinetics, cellular uptake, cytotoxicity, and in vivo therapeutic efficacy. The conclusions drawn from the study summarize the key findings, implications for future research, and the potential clinical relevance of the developed drug delivery system for targeted cancer therapy. In conclusion, the development of a novel drug delivery system for targeted cancer therapy represents a significant advancement in the field of oncology, offering a promising avenue for improving treatment outcomes and patient quality of life. This thesis contributes to the growing body of knowledge on innovative drug delivery technologies and sets the stage for further research and development in the quest to combat cancer effectively.